Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr; ASCO.

J Clin Oncol. 2006 Nov 20;24(33):5313-27. Epub 2006 Oct 23.

PMID:
17060676
3.

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr; American Society of Clinical Oncology.

J Clin Oncol. 2007 Nov 20;25(33):5287-312. Epub 2007 Oct 22. Review.

PMID:
17954709
4.

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O.

Eur J Cancer. 2007 Jun;43(9):1348-60. Epub 2007 May 18. Review.

PMID:
17512720
5.

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.

Oncology. 2006;70(5):366-77. Epub 2006 Dec 15.

PMID:
17179731
6.

p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.

Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P, Solomon MJ.

Dis Colon Rectum. 2003 Feb;46(2):192-202.

PMID:
12576893
7.

Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.

Goldstein MJ, Mitchell EP.

Cancer Invest. 2005;23(4):338-51. Review.

PMID:
16100946
8.

[Standards, options and recommendations for tumor markers in colorectal cancer].

Eche N, Pichon MF, Quillien V, Gory-Delabaere G, Riedinger JM, Basuyau JP, Daver A, Buecher B, Conroy T, Dieu L, Bidart JM, Deneux L; Groupe de travail Nicole Eche (coordonnateur), oncobiologiste.

Bull Cancer. 2001 Dec;88(12):1177-206. Review. French.

9.

Prognostic and predictive factors in colorectal cancer.

Bolocan A, Ion D, Ciocan DN, Paduraru DN.

Chirurgia (Bucur). 2012 Sep-Oct;107(5):555-63. Review.

10.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

11.

Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.

Gasser M, Gerstlauer C, Grimm M, Bueter M, Lebedeva T, Lutz J, Maeder U, Ribas C, Ribas C, Nichiporuk E, Thalheimer A, Heemann U, Thiede A, Meyer D, Waaga-Gasser AM.

Ann Surg Oncol. 2007 Apr;14(4):1272-84. Epub 2007 Jan 9.

PMID:
17211733
12.

Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.

Kumar Y, Tapuria N, Kirmani N, Davidson BR.

Eur J Gastroenterol Hepatol. 2007 Mar;19(3):265-76. Review.

PMID:
17301655
13.

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O.

Eur J Cancer. 2003 Apr;39(6):718-27. Review.

PMID:
12651195
14.

The use of serologic tumor markers in gastrointestinal malignancies.

Posner MR, Mayer RJ.

Hematol Oncol Clin North Am. 1994 Jun;8(3):533-53. Review.

PMID:
8707771
15.
16.

Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.

Liu ZP, Li LM, Liu XL, Zhang DX.

Onkologie. 2012;35(3):108-13. doi: 10.1159/000336816. Epub 2012 Feb 20.

PMID:
22414974
17.

Diagnostic value of serum tumor markers in asymptomatic individuals.

Eleftheriadis N, Papaloukas C, Pistevou-Gompaki K.

J BUON. 2009 Oct-Dec;14(4):707-10.

PMID:
20148467
19.

[Thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in soft-tissue sarcoma versus capecitabine potential].

Stepanova EV, Bokhian BIu, Petrovichev NN, Lichinitzer MR.

Vopr Onkol. 2005;51(3):314-6. Russian.

PMID:
16279094
20.

[Gastrointestinal cancer].

Takahashi Y.

Gan To Kagaku Ryoho. 2004 Aug;31(8):1275-9. Review. Japanese.

PMID:
15332558

Supplemental Content

Support Center